Clinical Trial Update: Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating PET imaging in Stage III non-small cell lung cancer (the PET START trial) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Non-Small-Cell Lung Carcinoma | Phase 3 | Status: COMPLETED